Schizophreniform disorder
MONDO:0001265A disorder that differs from schizophrenia specifically in total duration (schizophreniform disorder lasts at least 1 month but less than 6 months whereas schizophrenia lasts at least 6 months); schizophreniform disorder also typically causes less impairment in the individual's social and occupational functioning.
122 clinical trials for this condition and its sub-types, 72 tagged with Schizophreniform disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Brain training from home: could a smartphone app sharpen thinking in early psychosis?
Disease control OngoingThis study tests whether a 12-week mobile program can improve cognitive function and motivation in people aged 15–40 who have had psychosis symptoms for less than five years. Participants will either use the mobile training or continue their usual care, and researchers will compa…
Sponsor: University of Minnesota • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can a new therapy curb violence in young psychosis patients?
Disease control OngoingThis small pilot study tests a behavioral therapy called PICASSO, designed to help young adults (ages 16-30) with early psychosis who have shown violent behavior. The therapy uses cognitive behavioral techniques to address anger and violence. The study will check if the therapy i…
Sponsor: Columbia University • Aim: Disease control
Last updated Jun 26, 2026 13:24 UTC
-
Writing your way to wellness: new study tests creative writing for mental health
Symptom relief OngoingThis study tests a 15-session creative writing program called REWRITALIZE for people with serious mental illnesses like schizophrenia, bipolar disorder, or severe depression. About 300 adults will either join the writing groups plus their usual care, or stay on a waiting list wit…
Sponsor: Amager Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
ER agitation study pulled before it began
Symptom relief CancelledThis study aimed to see if a dissolvable film placed under the tongue could quickly calm agitation in people with bipolar disorder or schizophrenia who come to the emergency room. The drug, BXCL501, is already approved for this use, but the study wanted to test it in the ER setti…
Phase 4 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Can magnetic pulses unlock memory secrets in early psychosis?
Knowledge-focused OngoingThis study uses a noninvasive brain stimulation technique called TMS, combined with brain scans, to understand working memory problems in people with early psychosis. Twenty participants will receive both active and placebo TMS to see how it affects brain activity and memory perf…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Gut bugs linked to antipsychotic weight gain in youth
Knowledge-focused OngoingThis study looks at how gut bacteria change when young people (ages 12-35) with psychosis start taking antipsychotic medication. Researchers want to see if these changes are linked to weight gain and other metabolic problems. Participants provide stool and blood samples over 12 w…
Sponsor: Centre for Addiction and Mental Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC